Particle.news
Download on the App Store

Amphetamine-Type Stimulants Now Dominate Workplace Drug Positives

The Drug Detection Agency says this shift raises safety risks and urges employers to review testing and policy to match strong regional differences in drug use.

Overview

  • The agency's June-quarter report, released Wednesday, shows amphetamine-type stimulants made up 60% of all positive workplace drug tests, a 17.9% rise year-on-year.
  • Workplace cocaine detections in New Zealand climbed nearly 70% year-on-year with big increases in Canterbury and Otago, the agency said.
  • Opioid detections fell about 36% year-on-year to 11.6% of positives, and drugs were found in roughly 3% of all workplace screens, a rate broadly unchanged from recent quarters.
  • The report highlights stark regional hotspots: Western Australia for methamphetamine, South Australia for cocaine, Queensland for cannabis, and Victoria for opioids.
  • The agency, which conducts about 250,000 workplace tests a year, warned employers to update drug-and-alcohol policies and testing programs and noted its data mainly covers safety-sensitive workplaces but is expanding into white-collar sectors.